gliptin and glp-1 Glucagon-like peptide-1 GLP-1-RA and DPP-4 inhibitors in

Ozempic is a weekly GLP-1 injection (semaglutide), not a pill

For perimenopausal women, weight management becomes particularly challenging due to hormonal fluctuations that affect metabolism, appetite regulation, and body composition

News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s

For example, the semaglutide pen is not recommended to be used more than 56 days once started, he says